The intersection of artificial intelligence (AI) and healthcare presents a transformative frontier, particularly in the global fight against cancer. As healthcare systems worldwide grapple with rising ...

Forbes contributors publish independent expert analyses and insights. Fred L. Smith Jr. Fellow at the Competitive Enterprise Institute. Draft Report to Congress on the Benefits and Costs of Federal ...

GLP-1 RA tirzepatide may be more cost-effective for patients with obesity and knee osteoarthritis than semaglutide.

The Budget Lab at Yale aims to address gaps in current economic analysis. Founded last year by three former members of the Biden administration — Yale Law School professor Natasha Sarin ’11, ...

Current political and economic issues succinctly explained. Under both the Donald Trump and Joe Biden administrations, the U.S. government has had a seemingly unquenchable thirst for national security ...

The introduction of lebrikizumab, a novel monoclonal antibody targeting interleukin-13 for severe atopic dermatitis (AD), was associated with cost savings of approximately €3.3 million over 3 years ...

Tirzepatide and semaglutide would have to drop their current net prices by 30.5% and 81.9%, respectively, to be cost-effective. Over a lifetime of use, tirzepatide could avert 45,609 obesity cases, 20 ...

The arrival of the palm oil industry in Indonesia’s Papua region has wrought more than five times as much environmental and social damage than the benefits it has delivered, according to a new ...